|4Feb 22, 6:34 PM ET

Ahlberg Gregory A 4

4 · ABBOTT LABORATORIES · Filed Feb 22, 2023

Insider Transaction Report

Form 4
Period: 2023-02-17
Ahlberg Gregory A
Senior Vice President
Transactions
  • Award

    Common shares without par value

    2023-02-17+9,50442,557 total
  • Award

    Option (right to buy)

    2023-02-17+37,48337,483 total
    Exercise: $106.24From: 2024-02-17Exp: 2033-02-16Common Shares (37,483 underlying)
Holdings
  • Common shares without par value

    (indirect: By Trust)
    11,017
Footnotes (3)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2023.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,494 on February 17, 2024, 12,494 on February 17, 2025, and 12,495 on February 17, 2026.

Documents

1 file
  • 4
    form4-02222023_110235.xmlPrimary